
J Neuropsychiatry Clin Neurosci 19:81-83, February 2007
doi: 10.1176/appi.neuropsych.19.1.81
© 2007 American Neuropsychiatric Association
Clinical and Research Reports |
Treatment of Apathy With Methylphenidate
Prasad R. Padala, M.D.,
William J. Burke, M.D.,
Subhash C. Bhatia, M.D. and
Frederick Petty, Ph.D., M.D.
Received January 11, 2006; revised May 10, 2006; accepted June 2, 2006. Dr. Padala is affiliated with the Veterans Affairs Medical Center, and University of Nebraska Medical Center, Omaha, Nebraska. Dr. Burke is affiliated with the University of Nebraska Medical Center, Omaha, Nebraska. Drs. Bhatia and Petty are affiliated with the Veterans Affairs Medical Center and Creighton University, Omaha, Nebraska. Address correspondence to Dr. Padala, 4101 Woolworth Avenue, Omaha, NE 68105; ppadala{at}unmc.edu (e-mail).
ABSTRACT
Apathy is a common condition that transcends psychiatric diagnoses. Its treatment is not well studied. The authors present four cases of apathy treated with a regimen of methylphenidate. Significant improvement in apathy and its sub-domains (motivation, novelty, and persistence) were noted.
This article has been cited by other articles:

|
 |

|
 |
 
S E Starkstein and A F G Leentjens
The nosological position of apathy in clinical practice
J. Neurol. Neurosurg. Psychiatry,
October 1, 2008;
79(10):
1088 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2007
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|